Kory Lavine is a Cardiology physician affiliated with Amgen. OpenAlex indexes 324 publications with 18,653 citations (h-index 62).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1020 N Mason Rd
Div Im Cardiology, Ste 100
Saint Louis, MO 631416666
Telephone
314-362-1291Registry record last updated 17 Apr 2025.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20251 payment
- Kiniksa Pharmaceuticals, Ltd.Program year20233 payments
- Abbott LaboratoriesProgram year20232 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
55.4%Beta blocker18%Carvedilol81%Metoprolol Succinate19%Part D<11 patientsStatin15.5%Rosuvastatin Calcium60%Atorvastatin Calcium22%Pravastatin Sodium19%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
19.6%Proton pump inhibitor8.3%Pantoprazole Sodium68%Omeprazole32%Part D<11 patientsCorticosteroid7.8%Prednisone100%Part D≥17 patients+ 2 more classes in this area
Cancer & immunology
9.7%Calcineurin inhibitor7.4%Tacrolimus100%Part D≥13 patientsKinase inhibitor2.3%Sirolimus100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
7 NIH research awards on record, funded 2014–2026 per NIH RePORTER. The latest:
- Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure
Washington University
FY2026$914,340R35HL161185 - Pediatric Cardiovascular and Pulmonary Research Training Program.
Washington University
FY2026$405,847T32HL125241 - Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure
Washington University
FY2025$933,000R35HL161185
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A TRPV4-dependent neuroimmune axis in the spinal cord promotes neuropathic pain
Journal of Clinical Investigation
2023 - Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure
Nature Cardiovascular Research
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Anna Farago, MD, PhD
Amgen
Janet Franklin, MD
Amgen
Siddique Abbasi, MD
Amgen
Gaurav Suri
Amgen
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”